High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$22K
$22,420
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KROS
P
Keros Therapeutics, Inc.
BIENAIME JEAN JACQUES
• Director
Discretionary BuyΔOwn +36.7%
2026-03-09
$22,420
|
||||||
| KROS |
Keros Therapeutics, Inc.
|
Director
Discretionary BuyΔOwn +36.7%
|
2026-03-09 | $22,420 | P | Form 4 |